External use biological preparation for controlling vagina inflammation, and preparation method of external use biological preparation for controlling vagina inflammation

A biological preparation and inflammation technology, applied in the field of external biological preparation for preventing and treating vaginal inflammation and its preparation field, can solve the problems of weak antibacterial effect, destroying vaginal self-cleaning function, normal flora imbalance, etc., so as to improve self-cleaning function and sterilization. effect, easy-to-absorb effect

Pending Publication Date: 2020-06-05
大连富勒烯药业有限公司
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antibiotics have the best antibacterial effect, but they have the problem of destroying the self-cleaning function of the vagina and causing the imbalance of normal vaginal flora; Chinese medicine extracts also have good curative effects, but their pH is about 7.5, which will not only affect the gram-positive lactic acid The growth of dominant bacteria such as bacilli has a certain impact on the self-cleaning function of the vagina, and it is more irritating to the skin, sometimes causing side effects such as skin redness and swelling; the pH of the antibacterial peptide is about 3.8, which is conducive to vaginal self-cleaning, but the antibacterial effect is relatively weak

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External use biological preparation for controlling vagina inflammation, and preparation method of external use biological preparation for controlling vagina inflammation
  • External use biological preparation for controlling vagina inflammation, and preparation method of external use biological preparation for controlling vagina inflammation
  • External use biological preparation for controlling vagina inflammation, and preparation method of external use biological preparation for controlling vagina inflammation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] An external biological preparation for preventing and treating vaginal inflammation of the present invention is composed of the following raw materials in mass percentage: Sophora flavescens extract 2.5%, Poria cocos extract 2.5%, Angelica sinensis extract 0.4%, Wild chrysanthemum flower extract 0.4%, White lily flower extract 0.4%, North American witch hazel extract 0.4%, calendula flower extract 0.4%, 1,3-butanediol 6%, hydroxyethyl cellulose 0.2%, acryloyl dimethyl ammonium taurate / VP copolymer 0.75%, edetate disodium 0.3%, and antimicrobial peptides (BioMAPAs) 2.1%, the balance of water.

[0012] The preparation method is carried out according to the following steps:

[0013] a. Add 1,3-butanediol, hydroxyethyl cellulose, ammonium acryloyldimethyltaurate / VP copolymer, and water into the container and stir to dissolve evenly; heat the container to 85°C, add ethylene glycol Disodium amine tetraacetate, stirred at constant temperature for 30 minutes to obtain a blank...

Embodiment 2

[0018] The external biological preparation for preventing and treating vaginal inflammation of the present invention is composed of the following raw materials in mass percentage: 1% Sophora flavescens extract, 5% Poria cocos extract, 0.1% Angelica sinensis extract, 2% wild chrysanthemum flower extract, 0.1% white lily flower extract %, North American witch hazel extract 2%, calendula flower extract 0.1%, 1,3-butanediol 2%, hydroxyethyl cellulose 1%, acryloyl dimethyl taurate ammonium / VP copolymer 1%, disodium edetate 1%, and antimicrobial peptide 10%, the balance of water.

[0019] The preparation method and source of raw materials are the same as in Example 1.

Embodiment 3

[0021] The external biological preparation for preventing and treating vaginal inflammation of the present invention is composed of the following raw materials in mass percentage: Sophora flavescens extract 5%, Poria cocos extract 1%, Angelica sinensis extract 2%, Wild chrysanthemum flower extract 0.1%, White lily flower extract 2% %, North American witch hazel extract 0.1%, calendula flower extract 2%, 1,3-butanediol 8%, hydroxyethyl cellulose 2%, acryloyl dimethyl taurate ammonium / VP copolymer 2%, disodium edetate 2% and antimicrobial peptide 8%, the balance of water.

[0022] The preparation method and source of raw materials are the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an external use biological preparation for controlling vagina inflammation, wherein the acid environment with pH smaller than or equal to 4.5 of the vagina can be maintained, and the external use biological preparation has higher buffer capacity and good sterilizing effects and is non-irritant. The external use biological preparation consists of the following raw materialsin percentage by mass of 1-5% of a radix sophorae flavescentis extract, 1-5% of a poria cocos extract, 0.1-2% of a radix angelica sinensis extract, 0.1-2% of a wild chrysanthemum extract, 0.1-2% of awhite lily extract, 0.1-2% of a hamamelis extract, 0.1-2% of a calendula extract, 1-10% of 1,3-butanediol, 0.1-2% of hydroxyethyl cellulose, 0.1-2% of ammonium acryloyldimethyltaurate/VP copolymers, 0.1-2% of ethylenediamine tetraacetic acid disodium salt, 0.1-10% of antibacterial peptides and the balance water.

Description

technical field [0001] The present invention relates to a medicine for preventing and treating female reproductive tract inflammation, especially a kind of external biological preparation for preventing and treating vaginal inflammation which can maintain the acidic environment of vaginal pH ≤ 4.5, has strong buffer capacity and bactericidal effect, and is non-irritating. its preparation method. Background technique [0002] Female reproductive tract infection (Reproductive Tract Infection, RTI) is mainly an infectious disease that occurs in the female reproductive system, and is caused by various pathogenic microorganisms such as parasites, viruses, bacteria, fungi, and chlamydia. Gram-positive Lactobacilli are the dominant bacteria in the normal female reproductive tract flora. Lactobacillus decomposes glycogen in the vaginal mucosa epithelium in an acidic environment to produce lactic acid, and at the same time produces hydrogen peroxide and lactobacillus, which can effec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/02A61K9/06A61P15/02A61P31/04A61P31/10A61P31/02A61P33/02A61K36/8967
CPCA61K9/0034A61K9/06A61K36/076A61K36/185A61K36/232A61K36/28A61K36/287A61K36/489A61K36/8967A61K38/02A61K47/38A61P15/02A61P31/02A61P31/04A61P31/10A61P33/02A61K2300/00
Inventor 李伟佟长青李姹姹
Owner 大连富勒烯药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products